Home › Studies › PRJNA1445352
PRJNA1445352 SRP687878

Microbiota transplant therapy in children with Pitt-Hopkins

Microbiota Transplant Therapy (MTT) Improves Gastrointestinal Symptoms by Modulating Gut Microbiota in Children with Pitt-Hopkins Syndrome, A Rare Neurodevelopmental Disorder

62 gut microbiome samples from children with Pitt-Hopkins syndrome (a rare neurodevelopmental disorder), studying antibiotic, bowel preparation, and fecal microbiota transplant intervention in a randomized, placebo-controlled trial. machine-written summary

62 samples · 62 runs · US · Child · 2026 · 3.13 Gbp / sample

Sources
✓Sequence archive 621✓Abstract / description 65–Full text–Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive621 sample values (antibiotic exposure, collection date, country, health condition, intervention, intervention detail, latitude, location region)
✓ Abstract / description65 sample values (health condition, health condition detail)
– Full textno open-access full text linked
– Supplementary tablesno supplementary tables available (or none open access)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention · arms resolved

RFaecal microbiota transplantation: 6 people · 15 samplesFMT 6 people · 15 samplesAntibiotic given as the study intervention (incl. eradication therapy: 6 people · 12 samplesantibiotic 6 people · 12 samplesControl / pre-intervention baseline (sample level only): 26 people · 29 samplesno intervention 26 people · 29 samplesPlacebo / sham arm (sample level only): 3 people · 6 samplesplacebo 3 people · 6 samples
randomised to parallel arms

6 people have samples in more than one arm.

Antibiotic given as the study intervention (incl. eradication therapy Bowel cleansing / colonoscopy preparation Faecal microbiota transplantation design randomized_controlled_trial · population neurological_psychiatric · Microbiota transplant therapy with antibiotics and bowel cleansing pretreatment, RCT vs placebo

“combination of antibiotics, bowel cleansing, and transplant of healthy donor microbiota” — bioproject.description (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 sampling locations · 1 country
Age
child62
Condition
neurological_psychiatric45
malnutrition17
Country
US62
Body site
primary62
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)this project, 1–3 Gbp: 18 samplesall projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 44 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 3.13 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal — not resolved

6 of 26 people sampled more than once (42 samples; median 7, up to 8 per person).

How longitudinal and relatedness information is derived

Community composition

No Sandpiper profile for this project's samples yet.

Field coverage
fieldsamplescoverageR1R2R3R4
age_category62 100%
country62 100%62
health_condition62 100%593
subject_id62 100%62
collection_date62 100%62
detailed_location62 100%
health_condition_detail62 100%62
intervention62 100%62
intervention_detail62 100%62
latitude62 100%62
location_region62 100%62
longitude62 100%62
timepoint_label60 97%60
antibiotic_exposure6 10%6
Papers (1)
  • Microbiota Transplant Therapy (MTT) Improves Gastrointestinal Symptoms in Children with Pitt-Hopkins Syndrome: A Randomized Clinical Trial 2026 own_data
Details
Archive description

This study investigates Microbiota Transplant Therapy (MTT) as a treatment for children with Pitt-Hopkins Syndrome who suffer from gastrointestinal (GI) problems. It uses a combination of antibiotics, bowel cleansing, and transplant of healthy donor microbiota to restore gut balance. The trial is designed as a randomized, placebo-controlled study to assess safety, tolerability, and effectiveness. Results suggest that MTT can improve GI symptoms by reshaping the gut microbiome. The research also explores how changes in gut bacteria may influence broader neurological and behavioral symptoms in this rare disorder.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of child by deterministic_prior with confidence 0.90. Assay shotgun_dna.

  • host external_curation.infant_catalog · “infant triage reason_code age_child_over_36m”
  • body site study.title · “Therapy (MTT) Improves Gastrointestinal Symptoms by Modulating”
  • body site study.description · “who suffer from gastrointestinal (GI) problems. It”
  • life stage external_curation.infant_catalog · “infant triage reason_code age_child_over_36m”
  • life stage study.title · “Gut Microbiota in Children with Pitt-Hopkins Syndrome,”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN56787990antibiotic_exposureyesR10.85biosample.attribute:Group_for_case_controlGroup_for_case_control: Vanco
SAMN56787986collection_date2024R10.90biosample.attribute:collection_date2024
SAMN56787986countryUSR10.90sample.attr.geo_loc_nameUSA:Ariozna
SAMN56787986health_conditionneurological_psychiatricR10.85biosample_attrPlacebo
SAMN56787988health_conditionneurological_psychiatricR40.50study.titlePitt-Hopkins Syndrome, A Rare Neurodevelopmental Disorder
SAMN56787986health_condition_detailPitt-Hopkins Syndrome, a rare neurodevelopmental disorder with GI problems.R40.50study.titlePitt-Hopkins Syndrome, A Rare Neurodevelopmental Disorder
SAMN56787986interventionno_interventionR10.90biosample.attribute:Group_for_case_controlGroup_for_case_control: Baseline
SAMN56787987interventionantibioticR10.80biosample.attribute:ReGroupReGroup: Vanco
SAMN56787986intervention_detailPre-intervention baselineR10.90biosample.attribute:Group_for_case_controlGroup_for_case_control: Baseline
SAMN56787987intervention_detailVancomycin antibioticR10.80biosample.attribute:ReGroupReGroup: Vanco
SAMN56787986latitude33.4194R10.90biosample.attribute:lat_lon33.4194 N 111.9281 W
SAMN56787986location_regionArizonaR10.60biosample.attribute:lat_lon33.4194 N 111.9281 W
SAMN56787986longitude-111.9281R10.90biosample.attribute:lat_lon33.4194 N 111.9281 W
SAMN56787986subject_idPH002R10.85sample.attr.patient_idPH002
SAMN56787986timepoint_labelBaselineR10.85biosample.attribute:Group_for_case_controlGroup_for_case_control: Baseline
Sequencing

62 runs over 62 samples · mean 3.21 Gbp per run (median 3.13 Gbp, total 198.82 Gbp; 62 runs with a base count) · layout PAIRED 62 · platform ILLUMINA 62 · models Illumina NovaSeq 6000 (62) · 0% of runs with a Sandpiper profile · first public 2026-04-05

Authors (0)

No author record.

Downloads

PRJNA1445352.csv.gz (2.9 KB) · parquet (73.6 KB) — all 62 samples, every field with route and confidence · PRJNA1445352_determinations.csv.gz (6.1 KB) — 686 evidence rows

Samples (62 · every field this project has values for · hover a cell for its source)
Loading the sample table…